Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 2NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lymphoma 4Breast Neoplasms 4Sarcoma 3Rhabdomyosarcoma 2Ovarian Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Lung Neoplasms 2Inflammatory Breast Neoplasms 2Fallopian Tube Neoplasms 2Carcinoma 2Teratoma 1Sarcoma, Synovial 1Recurrent Uterine Corpus Sarcoma 1Recurrent Uterine Corpus Carcinoma 1Pancreatic Neoplasms 1Neutropenia 1Neurofibrosarcoma 1Malignant mesenchymal tumor 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Follicular 1Liposarcoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Leiomyosarcoma 1Kidney Neoplasms 1Hodgkin Disease 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Fibrosarcoma 1Esophageal Squamous Cell Carcinoma 1

Interventions

Paclitaxel 14Carboplatin 14Radiotherapy 11Cisplatin 7Bevacizumab 7Docetaxel 5Cetuximab 4Erlotinib Hydrochloride 3Vinorelbine 2Surgical Procedures, Operative 2Radiotherapy, Conformal 2Radiosurgery 2Gemcitabine 2Etoposide 2Amplified Fragment Length Polymorphism Analysis 2sotorasib 1rucaparib 1pegfilgrastim 1Therapeutics 1Temozolomide 1Taxes 1Polymerase Chain Reaction 1Pneumonectomy 1Pharmacogenomic Testing 1Pemetrexed 1Panitumumab 1Neoadjuvant Therapy 1L-BLP25 1Injections 1Immunohistochemistry 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Adenocarcinoma of Lung × pegfilgrastim × Clear all
NCT00113386 2013-06-28

Cisplatin and Docetaxel With or Without Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Newly Diagnosed Stage III Non-Small Cell Lung Cancer

Radiation Therapy Oncology Group

Phase 3 Terminated
19 enrolled 5 charts
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡